Geoffrey Barker, Ph.D. serves as our Chief Development Officer. Dr. Barker has 30 years of pharmaceutical and nonclinical development experience. Before being appointed as Chief Development Officer, Dr. Barker served as Senior Vice President of Pharmaceutical Development at Viking Therapeutics. Prior to joining Viking, he was Project Director at Pyramid Laboratories, a fill/finish aseptic manufacturing facility. Before joining Pyramid, Dr. Barker was senior director of Product Development at Aires Pharmaceuticals, Inc., a company focused on developing therapies for pulmonary vascular disorders. Dr. Barker has also previously served as associate director of pharmaceutical development at TargeGen, Inc., where he oversaw the development of two Phase 2 candidates and one Phase 1 candidate for the treatment of hematological malignancies and certain other disorders and as a scientist at Merck and Company (previously SIBIA Neurosciences), a biotech company focused on central nervous system disorders. Dr. Barker earned a Ph.D. in analytical chemistry from the State University of New York at Binghamton.